Literature DB >> 16047273

Homocysteine and cognitive function.

Aron Troen1, Irwin Rosenberg.   

Abstract

The prevention and treatment of age-related cognitive impairment and dementia is one of the greatest and most elusive challenges of our time. The prevalence of dementia increases exponentially with age, as does the prevalence of those with micronutrient deficiency. Several studies have shown that elevated homocysteine is correlated with cognitive decline and with cerebral atrophy and that it predicts the subsequent development of dementia in cognitively intact middle-aged and elderly individuals. If elevated homocysteine promotes cognitive dysfunction, then lowering homocysteine by means of B-vitamin supplementation may protect cognitive function by arresting or slowing the disease process.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16047273     DOI: 10.1055/s-2005-872406

Source DB:  PubMed          Journal:  Semin Vasc Med        ISSN: 1528-9648


  13 in total

Review 1.  Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy.

Authors:  Bruce Hermann; Michael Seidenberg; Mark Sager; Cynthia Carlsson; Barry Gidal; Raj Sheth; Paul Rutecki; Sanjay Asthana
Journal:  Epilepsia       Date:  2007-11-21       Impact factor: 5.864

2.  B-Vitamin Therapy for Kidney Transplant Recipients Lowers Homocysteine and Improves Selective Cognitive Outcomes in the Randomized FAVORIT Ancillary Cognitive Trial.

Authors:  T M Scott; G Rogers; D E Weiner; K Livingston; J Selhub; P F Jacques; I H Rosenberg; A M Troen
Journal:  J Prev Alzheimers Dis       Date:  2017

3.  Asymmetric dimethylarginine is not elevated in exfoliation syndrome but symmetric dimethylarginine is related to exfoliative glaucoma.

Authors:  Hillevi Blomster; Tuomo Puustjärvi; Matti Kontkanen; Pirjo Valtonen; Markku Teräsvirta; Hannu Uusitalo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02       Impact factor: 3.117

4.  Cognitive dysfunction and depression in adult kidney transplant recipients: baseline findings from the FAVORIT Ancillary Cognitive Trial (FACT).

Authors:  Aron M Troen; Tammy M Scott; Kristen E D'Anci; Denish Moorthy; Beverly Dobson; Gail Rogers; Daniel E Weiner; Andrew S Levey; Gerard E Dallal; Paul F Jacques; Jacob Selhub; Irwin H Rosenberg
Journal:  J Ren Nutr       Date:  2011-12-06       Impact factor: 3.655

5.  Homocysteine but not neopterin declines in demented patients on B vitamins.

Authors:  B Frick; B Gruber; K Schroecksnadel; F Leblhuber; D Fuchs
Journal:  J Neural Transm (Vienna)       Date:  2006-09-21       Impact factor: 3.575

6.  Cognitive dysfunction in cancer patients: an educational needs area improved by a single intervention.

Authors:  Irene Perez Vetto; John T Vetto
Journal:  J Cancer Educ       Date:  2007       Impact factor: 2.037

7.  Homocysteine levels and cognitive function scores measured with MMSE and BCAT of middle-aged and elderly subjects in Tianjin City.

Authors:  H Y Kong; D M Cheng; W Pang; S D Sun; J Liu; C Y Huang; Y G Jiang
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

8.  B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice.

Authors:  Aron M Troen; Melissa Shea-Budgell; Barbara Shukitt-Hale; Donald E Smith; Jacob Selhub; Irwin H Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-18       Impact factor: 11.205

9.  Cerebral perfusion and oxygenation are impaired by folate deficiency in rat: absolute measurements with noninvasive near-infrared spectroscopy.

Authors:  Bertan Hallacoglu; Angelo Sassaroli; Sergio Fantini; Aron M Troen
Journal:  J Cereb Blood Flow Metab       Date:  2011-03-09       Impact factor: 6.200

10.  Correlation of homocysteine metabolic enzymes gene polymorphism and mild cognitive impairment in the Xinjiang Uygur population.

Authors:  Mei Luo; Huihui Ji; Xiaohui Zhou; Jie Liang; Ting Zou
Journal:  Med Sci Monit       Date:  2015-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.